Leslie Trigg
Fortune : 1 M $ au 30/06/2026
Fortune : 1 M $ au 30/06/2026
Leslie L.
Trigg is Chairman, President & Chief Executive Officer at Outset Medical, Inc. since 2022.
Ms. Trigg is Director at The Medical Device Manufacturers Association.
Ms. Trigg is Independent Director at ARYA Sciences Acquisition Corp.
IV since 2021.
Ms. Trigg is Advisor at Vensana Capital Management LLC.
Former roles include Director-Business Unit at Cytyc Corp.
in 2002, Director-Market Development at Pro-Duct Health, Inc. in 2001, Independent Director at Cardiovascular Systems, Inc. from 2010 to 2017, Independent Director at EXACT Sciences Corp.
from 2025 to 2026, Independent Director at Adaptive Biotechnologies Corp., Senior Manager-Product at Guidant Corp., Executive-in-Residence at Warburg Pincus LLC in 2014, Vice President-Marketing at FoxHollow Technologies, Inc. in 2006, Chief Business Officer and SVP-Sales & Marketing at Access Closure, Inc. from 2006 to 2009, and Executive VP-Marketing & Commercial Strategy at Lutonix, Inc. from 2010 to 2012.
Education includes undergraduate studies at Northwestern University and an MBA from Haas School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OUTSET MEDICAL, INC. 1,35 % | 26/06/2026 | 240 284 ( 1,35 % ) | 1 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OUTSET MEDICAL, INC. | Directeur Général | 01/11/2014 |
| ARYA SCIE | Directeur/Membre du Conseil | 25/02/2021 |
The Medical Device Manufacturers Association
The Medical Device Manufacturers Association Miscellaneous Commercial ServicesCommercial Services Operates as a trade association | Directeur/Membre du Conseil | - |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million. | Consultant / Advisor | - |
| Sociétés | Poste | Fin |
|---|---|---|
| EXACT SCIENCES CORPORATION | Directeur/Membre du Conseil | 23/03/2026 |
| CARDIOVASCULAR SYSTEMS, INC. | Directeur/Membre du Conseil | 21/02/2017 |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Corporate Officer/Principal | 01/01/2014 |
Lutonix, Inc.
Lutonix, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug coated balloon catheters | Sales & Marketing | 01/01/2012 |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Sales & Marketing | 01/06/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
EXACT Sciences Corp.
EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
FoxHollow Technologies, Inc.
FoxHollow Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures, and sells medical devices for the treatment of peripheral artery disease | Health Technology |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Health Technology |
Outset Medical, Inc.
Outset Medical, Inc. Medical SpecialtiesHealth Technology Operates as a pioneering medical technology company which develops and commercializes reimagining dialysis for patients & health care providers | Health Technology |
Pro-Duct Health, Inc.
Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Develops medical products for the evaluation of breast cancer | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Medical Device Manufacturers Association
The Medical Device Manufacturers Association Miscellaneous Commercial ServicesCommercial Services Operates as a trade association | Commercial Services |
Lutonix, Inc.
Lutonix, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug coated balloon catheters | Health Technology |
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Develops medical devices for treating peripheral and coronary artery disease | Health Technology |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million. | Finance |
ARYA Sciences Acquisition Corp. IV
ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national